Holen Sie sich die Stockscreener-App
6.08
0.16%
0.010
Schlusskurs vom Vortag:
$6.07
Offen:
$6.11
24-Stunden-Volumen:
5,163
Relative Volume:
0.18
Marktkapitalisierung:
$22.21M
Einnahmen:
$11.68M
Nettoeinkommen (Verlust:
$-8.85M
KGV:
-2.5228
EPS:
-2.41
Netto-Cashflow:
$-14.61M
1W Leistung:
-1.30%
1M Leistung:
-18.17%
6M Leistung:
-0.49%
1J Leistung:
+204.00%
1-Tages-Spanne:
$6.07
$6.19
1-Wochen-Bereich:
$6.0581
$6.4932
52-Wochen-Spanne:
$1.78
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Firmenname
Pulmatrix Inc
Sektor
Branche
Telefon
(888) 355-4440
Adresse
945 CONCORD STREET, FRAMINGHAM, MA
Vergleichen Sie PULM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
6.08 | 22.50M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2018-02-09 | Eingeleitet | H.C. Wainwright | Buy |
Pulmatrix Inc Aktie (PULM) Neueste Nachrichten
What analysts say about Pulmatrix Inc. stockDynamic capital growth - Autocar Professional
What drives Pulmatrix Inc. stock priceUnstoppable trading performance - Autocar Professional
What makes Pulmatrix Inc. stock price move sharplyFree Long-Term Wealth Growth Plan - Newser
Is Pulmatrix Inc. a good long term investmentExplosive returns - jammulinksnews.com
Pulmatrix Inc. Stock Analysis and ForecastRapid growth opportunities - jammulinksnews.com
What analysts say about Pulmatrix Inc. stock outlookCapital Preservation Investment Ideas - Newser
Long Term Trading Analysis for (PULM) - news.stocktradersdaily.com
Reviewing Pulmatrix (NASDAQ:PULM) and Vanda Pharmaceuticals (NASDAQ:VNDA) - Defense World
How high can Pulmatrix Inc. stock price go in 2025High Yield Opportunities - Newser
Why Pulmatrix Inc. stock attracts strong analyst attentionFree Investment Portfolio Suggestions - beatles.ru
How Pulmatrix Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser
(PULM) Technical Data - news.stocktradersdaily.com
PULM Trading Resumes: Pulmatrix Updates Investors | PULM Stock News - GuruFocus
Pulmatrix (PULM) Trading Halted Due to Volatility | PULM Stock News - GuruFocus
Pulmatrix (PULM) Trading Resumes as Investors Watch Closely | PU - GuruFocus
PULM Trading Temporarily Halted Due to Volatility | PULM Stock News - GuruFocus
PULM Trading Temporarily Halted Due to Volatility | PULM Stock N - GuruFocus
How to Take Advantage of moves in (PULM) - news.stocktradersdaily.com
Learn to Evaluate (PULM) using the Charts - news.stocktradersdaily.com
Financial Comparison: Pulmatrix (NASDAQ:PULM) & Acelyrin (NASDAQ:SLRN) - Defense World
Pulmatrix (NASDAQ:PULM) Now Covered by StockNews.com - Defense World
(PULM) Trading Advice - news.stocktradersdaily.com
Pulmatrix set for merger with Cullgen, seeks asset divestment By Investing.com - Investing.com South Africa
Enliven stops work on solid tumor drug; Pulmatrix to divest assets - Endpoints News
Pulmatrix Announces Divestment Plan for Assets - citybiz
Pulmatrix Announces First Quarter 2025 Financial Results and Div - GuruFocus
Pulmatrix, Inc. SEC 10-Q Report - TradingView
Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets | PULM Stock News - GuruFocus
Pulmatrix set for merger with Cullgen, seeks asset divestment - Investing.com
Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets - WV News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDUS, COOP, ICAD, PULM on Behalf of Shareholders - The Malaysian Reserve
2025-05-13 | SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDUS, COOP, ICAD, PULM on Behalf of Shareholders | NDAQ:ICAD | Press Release - Stockhouse
PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc.PULM - marketscreener.com
Finanzdaten der Pulmatrix Inc-Aktie (PULM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):